![Philip Bedford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip Bedford
Keine laufenden Positionen mehr
Karriereverlauf von Philip Bedford
Ehemalige bekannte Positionen von Philip Bedford
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Glaxo Wellcome Plc | Corporate Officer/Principal | 01.01.1997 | 01.01.1997 |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
General Counsel | - | - | |
Adjuvantix Ltd.
![]() Adjuvantix Ltd. BiotechnologyHealth Technology Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom. | Direktor/Vorstandsmitglied | 16.10.2009 | - |
Statistik
International
Vereinigtes Königreich | 4 |
Operativ
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Adjuvantix Ltd.
![]() Adjuvantix Ltd. BiotechnologyHealth Technology Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
Glaxo Wellcome Plc | Health Technology |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Börse
- Insiders
- Philip Bedford
- Erfahrung